The names Meldrew, Victor Meldrew
- Edit My Images
shows that protection may be as low as 10%
Is the Oxford vaccine effective against the South African strain of Covid?
A small study of 2,000 people in South Africa has shown that the Oxford/AstraZeneca vaccine offers minimal protection against mild cases of the South African variant.
The study, which was based people of an average age of 31, shows that protection may be as low as 10%. The research wasn’t able to determine whether it protects against serious illness or hospitalisation, because this group of people were at low risk of serious illness. Other research suggests that the vaccine is still likely to reduce severe cases and deaths from the South African strain. More research is needed in this area.